Oramed Pharm share price logo

Oramed Pharm

NASDAQ: ORMP

$4.67

+0.01

(+0.21%)

as on

Oramed Pharm Stock Performance

as on September 15, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $4.65
    $4.76
    downward going graph

    0.43%

    Downside

    1.93%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.09
    $5.47
    downward going graph

    55.25%

    Downside

    17.13%

    Upside

    downward going graph

Oramed Pharm share price movements today

Previous Close
$4.66
Open
$4.66
Volume
242.1K
Market Cap
$193.8M
Dividend Yield
6.58%
Day's Low - High
$4.65 - $4.76
52 Week Low - High
$2.09 - $5.47

Oramed Pharm Historical Returns

1 Month Return
+ 4.24 %
3 Month Return
+ 21.61 %
1 Year Return
+ 101.29 %
3 Year Return
+ 53.62 %
5 Year Return
-75.99 %

Oramed Pharm Stock Fundamentals & Key Indicators

Check Oramed Pharm market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$193.8M

EPS (TTM)

4.47

Dividend Yield

6.58%

Quarterly Earnings Growth YOY

4.93%

PE Ratio (TTM)

1.13

Industry PE ratio

-1.78

PEG Ratio

0

EBITDA

-14.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

74.24%

Oramed Pharm Stock Valuation

Track how Oramed Pharm P/E has moved over time to understand its valuation trends.

Oramed Pharm in the last 5 years

  • Overview

  • Trends

Lowest (-25.81x)

November 30, 2021

Industry (-1.78x)

September 15, 2026

Today (1.13x)

September 15, 2026

Highest (16.43x)

November 30, 2023

LowHigh

Today’s Price to Earnings Ratio: 1.13x

Oramed Pharm vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oramed Pharm with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
HOLD$193.8M-75.99%1.130.00%657.89%
BUY$44.6B614.61%NA0.00%NA
BUY$130.6B175.08%29.7686.04%NA
BUY$57.5B-66.24%-18.04-12.57%NA
BUY$80.5B21.74%18.9584.86%47.339999999999996%

Stock Returns calculator for Oramed Pharm Stock including INR - Dollar returns

The Oramed Pharm stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Oramed Pharm investment value today

Current value as on today

₹2,18,238

Returns

₹1,18,238

(+118.24%)

Returns from Oramed Pharm Stock

₹1,01,293 (+101.29%)

Dollar Impact

₹16,945 (+16.94%)

Analyst Recommendation on Oramed Pharm Stock

Based on 7 analysts

HOLD

0.00%

Buy

57.14%

Hold

42.86%

Sell

Based on 7 analysts, 57.14% of analysts recommend a 'HOLD' rating for Oramed Pharm. Average target price of $7

Oramed Pharm Share Price Target

Get share price movements and forecasts by analysts on Oramed Pharm.

What analysts predicted

33.29%UPSIDE

Target Price

$7

Current Price

$4.67

Analyzed by

7 Analysts

Target

$7.00

Oramed Pharm target price $7, a slight upside of 33.29% compared to current price of $4.67. According to 7 analysts rating.

Indian Investors' Interest in Oramed Pharm Stock

Search interest for Oramed Pharm Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:20% versus previous 30 day period

Oramed Pharm Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
2
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
-
Operating Income
-2
-3
-3
-3
-4
-2
-2
-5
-3
-2
EBITDA
2
11
-18
-3
-4
13
59
-5
-3
101
Interest Expense
0
0
15
15
2
-
-
0
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
1
10
-18
-9
-7
13
59
9
49
101
Income Tax Expense
-
1
1
0
0
0
11
0
11
23
Net Income
1
9
-19
-10
-7
13
48
10
38
78
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-382.10%
0.00%
0.00%
0.00%
0.00%
0.00%

Oramed Pharm Annual Profit & Loss

All numbers in Millions USD

Aug 2020
Dec 2020
Aug 2021
Dec 2021
Aug 2022
Dec 2022
Aug 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2
2
2
2
2
2
2
1
-
2
Gross Profit
-
2
-
2
-
2
-
1
0
0
Operating Income
-
-11
-
-24
-
-40
-
-15
-12
-15
EBITDA
-
-11
-
-24
-
-36
-
7
-14
75
Interest Expense
-
-
-
0
-
2
-
3
0
-
Depreciation
-
0
-
0
-
0
-
0
0
0
Income Before Tax
-
-11
-
-22
-
-37
-
5
-15
75
Income Tax Expense
-
0
-
-2
-
0
-
-
3
11
Net Income
-11
-11
-22
-22
-36
-37
-37
5
-19
64
Net Profit Margin
-424.76%
-424.76%
-822.72%
-822.72%
-1352.61%
-1397.11%
-1397.11%
412.31%
0.00%
3202.50%

Oramed Pharm Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
9
-19
-10
-7
13
48
10
38
78
Operating Cash Flow
2
-7
-1
-3
-3
-1
0
-2
0
Investing Cash Flow
93
-33
15
23
-55
38
-1
-19
4
Financing Cash Flow
-30
-1
-1
-
0
0
-4
-10
-1
Change in Cash
66
-42
12
20
-58
36
-6
-32
2

Oramed Pharm Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-10
-12
-14
-11
-22
-36
5
-19
64
Operating Cash Flow
-5
-14
-12
-12
-21
-28
-10
-8
-9
Investing Cash Flow
4
-7
11
4
-22
30
-73
105
5
Financing Cash Flow
1
22
-
23
101
11
51
-52
-4
Change in Cash
0
1
-1
15
57
-36
-31
45
-8

Mutual Funds that own Oramed Pharm Stock

Check out the Mutual Funds with significant holdings in Oramed Pharm.

Funds
Holdings
Shares Held
DFA INVESTMENT DIMENSIONS GROUP INC
0.138693%
57693
RBC Funds Trust
0.108901%
45300
Nationwide Mutual Funds
0.078077%
32478
Fidelity Concord Street Trust
0.058373%
24282
Victory Portfolios III
0.018445%
7673

Global Institutional Holdings in Oramed Pharm

Funds
Holdings
iShares
2.54%
Vanguard
0.54%
Dimensional
0.21%
Avantis
0.14%
Goldman Sachs
0.14%

Insights on Oramed Pharm

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ORMP has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, ORMP stock has moved up by 101.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 514.3% return, outperforming this stock by 413.0%

About Oramed Pharm

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
OrganisationOramed Pharm
Headquarters1185 Avenue of the Americas, New York, NY, United States, 10036
IndustryBiotechnology
CEOMr. Nadav Kidron Esq.
E-voting on sharesClick here to vote

Key Management of Oramed Pharm

Name

Title

Mr. Nadav Kidron Esq.

President, CEO & Executive Chairman

Mr. Joshua Hexter

Chief Operating & Business Officer

Dr. Miriam Kidron Ph.D.

Chief Scientific Officer & Director

Mr. Avraham Gabay

CFO, Treasurer & Secretary

FAQs

What is Oramed Pharm share price today?

Oramed Pharm share price today is $4.67 as on at the close of the market. Oramed Pharm share today touched a day high of $4.76 and a low of $4.65.

What is the 52 week high and 52 week low for Oramed Pharm share?

Oramed Pharm share touched a 52 week high of $5.47 on and a 52 week low of $2.09 on . Oramed Pharm stock price today i.e. is closed at $4.67,which is 14.63% down from its 52 week high and 123.44% up from its 52 week low.

What is Oramed Pharm's market capitalisation today?

Oramed Pharm market capitalisation is $0.00T as on .

How to invest in Oramed Pharm Stock (ORMP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Oramed Pharm on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Oramed Pharm Shares that will get you 0.3212 shares as per Oramed Pharm share price of $4.67 per share as on September 15, 2026 at 8:45 am IST.

What is the minimum amount required to buy Oramed Pharm Stock (ORMP) from India?

Indian investors can start investing in Oramed Pharm (ORMP) shares with as little as ₹95.54 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in Oramed Pharm stock (as per the Rupee-Dollar exchange rate as on ). Based on Oramed Pharm share’s latest price of $4.67 as on September 15, 2026 at 8:45 am IST, you will get 2.1413 shares of Oramed Pharm. Learn more about fractional shares .

What are the returns that Oramed Pharm has given to Indian investors in the last 5 years?

Oramed Pharm stock has given -75.99% share price returns and 29.75% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?